Tuesday, 9 November 2010

Survey of PCTs shows access to Sativex limited

From the MS Trust
A survey conducted by financial analysts, Nomoura Code, suggests that many local funding bodies are not recommending Sativex as a treatment for spasticity in multiple sclerosis with many viewing it as low priority.  Read more here.